Jump to content
Crime Forum
FORUMS BLOG/NEWS USER BLOGS USER MEDIA ADVERTS   ADD  MANAGE CHAT CLUBS & USER'S PERSONAL FORUMS LINK EXCHANGE

Search the Community

Showing results for tags 'pharma'.

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


Forums

  • CRIME
    • General Chat on Crime
    • Forum about the Famous Criminals in the history.
    • Victims of Crimes Against the Person
    • Forum on Sexual Offences
    • Victims of Crimes against Property
    • Forum on Crimes against the Public
    • Forum on Self Defence and Defence of Property
  • CRIMINAL JUSTICE
    • General Chat on Criminal Justice
    • Forum on the punishment of the perpetrators of crimes
    • Forum on the conditions of life of Prisoners in Prison
    • Forum on Juvenile Delinquency
  • CRIMINAL LAW
    • General Chat on Criminal Law
    • Forum on the Death Penalty and Torture
    • Forum on proposals for reform of criminal law
    • Forum on the legalization of soft drugs.
  • HOME SECURITY
    • General Chat on Home Security Systems
    • Forum on Gun Control
  • LAW ENFORCEMENT
    • General Chat on Law Enforcement
    • Forum on Federal Bureau of Investigation (FBI)
    • Forum on Drug Enforcement Administration (DEA)
    • Forum on Law enforcement in the United Kingdom
    • Forum on Law enforcement in Canada, Australia, New Zealand and Ireland
  • Blog against the Death Penalty and Torture's Death Penalty and Torture in the world

Blogs

  • Blog in favor of legalization of soft drugs
  • Increase Gun Control in the United States and particularly in California.
  • The drug repurposing service providers market is estimated to be worth USD 1.2 billion in 2030
  • Growing at an annualized rate of over 9%, the antibody discovery services market
  • The global digital biomarkers market is projected to be worth over USD 22 billion by 2030

Find results in...

Find results that contain...


Date Created

  • Start

    End


Last Updated

  • Start

    End


Filter by number of...

Joined

  • Start

    End


Group


About Me

  1. https://www.rootsanalysis.com/reports/view_document/preventive-vaccines/318.html Key Inclusions § A detailed assessment of the current market landscape, including information on type of developer (industry, non-industry, industry / non-industry), phase of development (phase I, phase I/II, phase II, phase II/III, phase III and preregistration) of lead candidates, route of administration (intramuscular, intranasal, oral, intradermal, subcutaneous, intravenous and others), type of vaccine API (live, attenuated vaccine, recombinant vaccine, conjugate vaccine, inactivated vaccine,
  2. Technical advances, especially in the field of biotechnology, have led to the development of several next generation preventive vaccines, including recombinant vaccines, viral vector based vaccines and DNA vaccines, which have been demonstrated to elicit powerful immune responses, resulting in the development of immunological memory. To order this 250+ page report, which features 85+ figures and 125+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/preventive-vaccines/318.html The USD 94 billion (by 2030) financial opportunity within the g
  3. Roots Analysis has done a detailed report on Global Preventive Vaccines Market, 2020-2030”, covering key aspects of the industry and identifying potential future growth opportunities. To order this 250+ page report, which features 85+ figures and 125+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/preventive-vaccines/318.html Key Market Insights § More than 200 preventive vaccines, developed by both industry and non-industry players, are being evaluated in clinical stages of development § A variety of vaccine APIs, designed
  4. Although vaccines were solely responsible for the global eradication of smallpox (1980) and polio (2015), several vaccine-preventable diseases, such as measles and mumps, are still a threat; COVID-19 has been recently added to the list Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Preventive Vaccines Market, 2020-2030”. The report features an extensive study of the current market landscape and future opportunities associated with the preventive vaccine domain. The study also features a detailed analysis of the key drivers and
  5. To order this detailed 480+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html Key Inclusions § A detailed assessment of the current market landscape, including information on drug developer(s), phase of development (marketed, clinical and preclinical / discovery stage) of lead candidates, target immune checkpoints, their respective mechanisms of action (inhibitory or stimulatory), type of therapeutic modality used (monoclonal antibody, antibody fragment, small molecule and others), r
  6. Despite the fact that biopharmaceuticals offer significant profit margins, innovator companies are plagued by high costs of development, complex production protocols and special procedures and equipment for fill / finish operations. Consequently, a number of drug manufacturers have demonstrated a preference for outsourcing fill / finish operations of such products. To order this 480+ page report, which features 350+ figures and 260+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html T
  7. Roots Analysis has done a detailed study on Biologics Fill / Finish Services Market, 2019-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities. To order this 480+ page report, which features 237 figures and 267 tables, please visit this - https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html Key Market Insights § Over 115 companies located in various regions across the globe claim to provide contract fill / finish services for various types of biopharma
  8. Roots Analysis is pleased to announce the publication of its recent study, titled, “Biologics Fill / Finish Services Market, 2019-2030.” The report features an extensive study on the contract service providers offering drug product manufacturing services within the biopharmaceutical industry. The study features in-depth analysis, highlighting the capabilities of a diverse set of companies that claim to specialize in fill / finish operations. Amongst other elements, the report includes: § A detailed review of the overall landscape of contract fill / finish services market for
  9. https://www.rootsanalysis.com/reports/sting-pathway-targeting-therapeutics-and-technologies-market.html Key Inclusions § A detailed assessment of the current market landscape of therapeutics targeting STING pathway, based on several parameters, such as type of STING modulator (agonist or antagonist), type of molecule (small molecules, cyclic dinucleotides, non-nucleotides, biologics and others), phase of development (discovery, preclinical and clinical), target therapeutic area(s), type of therapy (monotherapy and combination therapy), route of administration (i
  10. In recent years, the concept of STING pathway targeting therapeutics has generated a lot of enthusiasm within the medical science community. The growing popularity of this therapeutic technique has not only garnered the interest of several medical researchers (reflected in the increasing volume of scientific literature (1,000+ articles published since 2015) on this subject), but also industry stakeholders focused on drug development (evident in the growing number of clinical trials and the grants awarded for STING focused projects in the recent past). To order this 310+ page report
  11. Roots Analysis has done a detailed study on STING Pathway Targeting Therapeutics and Technologies, 2020-2030.”, covering key aspects of the industry and identifying future growth opportunities. To order this 310+ page report, which features 150+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/sting-pathway-targeting-therapeutics-and-technologies-market.html Key Market Insights § Many small / macro molecule-based STING pathway modulators are currently being evaluated as monotherapies as well as in combination with other drugs
  12. Roots Analysis is pleased to announce the publication of its recent study, titled, “STING Pathway Targeting Therapeutics and Technologies, 2020-2030.” The report features an extensive study of the current market landscape and future potential of these therapeutics and affiliated technologies, over the next decade. This study focuses specifically on small molecule STING modulators. The report features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain. In addition to other elements, the study includes: § A detailed assessment of
  13. Key Inclusions § A detailed review of the current landscape of companies offering contract manufacturing services for biologics, using microbial expression systems, along with information on their year of establishment, company size, location of headquarters, number and location of their production facilities, scale of operation (preclinical, clinical and commercial), type of biologic(s) manufactured (peptides / proteins, antibodies, vaccines, biosimilars, oligonucleotides, plasmid DNA and others), type of microbial expression system(s) used (bacterial, yeast and others), type of ferment
  14. Despite mammalian cell cultures being the preferred manufacturing approach for biologics, recent advances in microbial fermentation have enabled the development of versatile biomanufacturing systems, which are both robust and cost friendly. Presently, a number of service provider companies claim to offer end-to-end solutions, ranging from product development to commercial production, for microbial biologics. Given the obvious advantages of outsourcing, drug developers are likely to continue relying on contract service providers for various aspects of their respective microbial biologic develop
  15. Roots Analysis has done a detailed study on Microbial Contract Biomanufacturing Market, 2020-2030, covering key aspects of the industry and identifying potential future growth opportunities. To order this 320+ page report, which features 150+ figures and 150+ tables, please visit this - https://www.rootsanalysis.com/reports/microbial-contract-biomanufacturing-market.html Key Market Insights § Over 115 companies, across the world, claim to offer a variety of product development, manufacturing and support services, for various types of biologics that are manufactur
  16. Roots Analysis is pleased to announce the publication of its recent study, titled, “Microbial Contract Biomanufacturing Market, 2020-2030.” The report features an extensive study of the current market landscape and future opportunities associated with the microbial contract biomanufacturing market. It features a detailed analysis of key drivers and trends related to this evolving domain. In addition to other elements, the study includes: § A detailed review of the current landscape of companies offering contract manufacturing services. § Elaborate profiles of key play
  17. Roots Analysis has announced the addition of the “Microbial Contract Biomanufacturing Market, 2020-2030” report to its list of offerings. Despite mammalian cell cultures being the preferred manufacturing approach for biologics, recent advances in microbial fermentation have enabled the development of versatile biomanufacturing systems, which are both robust and cost friendly. Presently, a number of service provider companies claim to offer end-to-end solutions, ranging from product development to commercial production, for microbial biologics. Given the obvious advantages of outso
  18. To order this detailed 350+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/immune-checkpoint-inhibitors/303.html Key Inclusions § A detailed assessment of the current market landscape, including information on drug developer(s), phase of development (marketed, clinical and preclinical / discovery stage) of lead candidates, target immune checkpoints, their respective mechanisms of action (inhibitory or stimulatory), type of therapeutic modality used (monoclonal antibody, antibody fragment, small molecule and others), route of administrati
  19. Over time, significant strides have been made in immune checkpoint research, resulting in the discovery of several inhibitory (LAG-3, TIM-3, TIGIT, VISTA and B7-H3) and stimulatory receptors (OX40, ICOS, GITR, 4-1BB and CD40), which are being investigated as potential targets for therapy development. Further, studies of combinatorial immune checkpoint blockade / co-stimulation, targeting newly identified checkpoints along with known checkpoint inhibitor therapies, have demonstrated promising clinical outcomes as well. To order this 350+ page report, which features 140+ figures and
  20. Roots Analysis has done a detailed study on Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030., covering key aspects of the industry’s evolution and identifying potential future growth opportunities. To order this 350+ page report, which features 140+ figures and 170+ tables, please visit this link Key Market Insights § More than 150 industry players across the world are presently engaged in evaluating the potential of nearly 300 next generation immune checkpoint modulators for the treatment of multiple disease indications § The
  21. Therapies targeting novel inhibitory and stimulatory immune checkpoints have been shown to possess substantial therapeutic potential, both as monotherapies and in combination with other interventions, across multiple disease interventions Roots Analysis is pleased to announce the publication of its recent study, titled, “Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030.” The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade. It feat
  22. To order this 250+ page report, which features 140+ figures and 170+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/endocannabinoid-therapeutics/316.html Key Inclusions § A detailed assessment of the current market landscape of endocannabinoid system targeted therapeutics, providing information on phase of development (clinical, preclinical, and discovery stage) of lead candidates, target therapeutic area (s), route of administration (oral, topical, sublingual, oromucosal, inhalation and others), dosing frequency (once daily, twice daily, thri
  23. Over time, extensive R&D on the potential health benefits of cannabis, have enabled medical researchers to identify a number of pharmacologically active ingredients that offer clinical benefit, minus the addictive properties of the crude substance. Currently, several stakeholders in the pharmaceutical industry are actively engaged in the efforts to develop leads based on natural and synthetic derivatives of cannabinoids. To order this 250+ page report, which features 140+ figures and 170+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/endocannab
  24. Roots Analysis has done a detailed study on Endocannabinoid System Targeted Therapeutics Market, 2020-2030 “ covering key aspects of the industry’s evolution and identifying potential future growth opportunities. To order this 250+ page report, which features 140+ figures and 170+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/endocannabinoid-therapeutics/316.html Key Market Insights § More than 65 industry players across the world are presently engaged in evaluating the clinical applications of over180 cannabinoid-derivatives that
  25. So far, more than 100 different cannabinoids have been identified, and there is a growing body of evidence supporting the clinical benefits of this class of compounds in treating the symptoms of a wide variety of chronic health conditions Roots Analysis is pleased to announce the publication of its recent study, titled, Endocannabinoid System Targeted Therapeutics Market, 2020-2030 The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of endocannabinoid system targeting drugs, over the next decade. Th
×
  • Create New...